《2022 AUA/CUA/SUFU指南:女性复发性单纯性尿路感染》的非抗生素治疗

Interpretation of the 2022 AUA/CUA/SUFU guidelines for non-antibiotic treatment of recurrent uncomplicated urinary tract infections in women

尿路感染发病普遍,复发率高,超过半数的女性有过一次以上尿路感染的经历。因此对于女性复发性单纯性尿路感染患者而言,规范性地预防和治疗具有极其重要的意义。本文对美国泌尿外科协会(American Urological Association,AUA)、加拿大泌尿外科协会(Canadian Urological Association,CUA)及尿动力学、女性盆腔医学和泌尿生殖重建学会(Society of Urodynamics,Female Pelvic Medicine and Urogenital Reconstruction,SUFU) 2022年更新的女性复发性单纯性尿路感染指南进行了解读,并结合相关的循证医学证据进行了总结,以期对女性复发性单纯性尿路感染的临床预防与治疗有所帮助。

Urinary tract infection is a common disease with high recurrence rate.More than half of women have experienced at least one urinary tract infection in their lifetime.Therefore,for female patients with recurrent uncomplicated urinary tract infection,standardized prevention and treatment is of great significance.This article interprets the guidelines for women with recurrent uncomplicated urinary tract infections updated in 2022 by the American Urological Association,the Canadian Urological Association,and the Society of Urodynamics,Female Pelvic Medicine and Urogenital Reconstruction,and summarizes relevant evidence-based medical evidence,hoping to help the clinical prevention and treatment of recurrent uncomplicated urinary tract infections in women.